Is Foundayo the same as orforglipron?

Foundayo is the brand name for orforglipron, listed in this site's orforglipron full name. They name the same oral small-molecule GLP-1 receptor agonist, molecular weight about 735 daltons, FDA approved April 1, 2026 for chronic weight management. ATTAIN-1 randomized 3,127 adults. A research-chemical tablet labeled orforglipron is not that labeled product, and the approval does not cover an unapproved vial. This site does not rank brands. Full record at /compounds/orforglipron.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of glp-1 and metabolic peptides. Semaglutide, tirzepatide, retatrutide, and the rest of the incretin and glucagon receptor family.